News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,506 Results
Type
Article (40896)
Company Profile (267)
Press Release (680333)
Multimedia
Podcasts (82)
Webinars (17)
Section
Business (204661)
Career Advice (2023)
Deals (35532)
Drug Delivery (110)
Drug Development (81382)
Employer Resources (173)
FDA (16407)
Job Trends (14944)
News (346372)
Policy (32723)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2565)
Accelerated approval (31)
Adcomms (24)
Allergies (141)
Alliances (49575)
ALS (169)
Alzheimer's disease (1664)
Antibody-drug conjugate (ADC) (308)
Approvals (16673)
Artificial intelligence (510)
Autoimmune disease (151)
Automation (38)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (188)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (634)
Cancer (4782)
Cardiovascular disease (398)
Career advice (1708)
Career pathing (36)
CAR-T (280)
CDC (44)
Celiac Disease (2)
Cell therapy (740)
Cervical cancer (36)
Clinical research (69542)
Collaboration (1690)
Company closure (4)
Compensation (1155)
Complete response letters (54)
COVID-19 (2709)
CRISPR (87)
C-suite (834)
Cystic fibrosis (143)
Data (6196)
Decentralized trials (2)
Denatured (25)
Depression (131)
Diabetes (499)
Diagnostics (6683)
Digital health (48)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (250)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (230)
Earnings (90110)
Editorial (56)
Employer branding (21)
Employer resources (152)
Events (117241)
Executive appointments (970)
FDA (19509)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1462)
Gene editing (192)
Generative AI (43)
Gene therapy (591)
GLP-1 (965)
Government (4655)
Grass and pollen (6)
Guidances (383)
Healthcare (18870)
HIV (58)
Huntington's disease (44)
IgA nephropathy (81)
Immunology and inflammation (248)
Immuno-oncology (57)
Indications (109)
Infectious disease (2973)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (115)
Intellectual property (246)
Interviews (315)
IPO (16641)
IRA (49)
Job creations (3642)
Job search strategy (1428)
JPM (57)
Kidney cancer (15)
Labor market (85)
Layoffs (546)
Leadership (31)
Legal (7948)
Liver cancer (91)
Longevity (14)
Lung cancer (644)
Lymphoma (375)
Machine learning (42)
Management (59)
Manufacturing (791)
MASH (162)
Medical device (13765)
Medtech (13818)
Mergers & acquisitions (19959)
Metabolic disorders (1262)
Multiple sclerosis (160)
NASH (16)
Neurodegenerative disease (314)
Neuropsychiatric disorders (87)
Neuroscience (2886)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4512)
Now hiring (67)
Obesity (592)
Opinion (257)
Ovarian cancer (166)
Pain (197)
Pancreatic cancer (225)
Parkinson's disease (279)
Partnered (33)
Patents (491)
Patient recruitment (482)
Peanut (56)
People (58849)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21679)
Phase 2 (30609)
Phase 3 (22798)
Pipeline (5219)
Policy (279)
Postmarket research (2564)
Preclinical (9195)
Press Release (64)
Prostate cancer (236)
Psychedelics (48)
Radiopharmaceuticals (279)
Rare diseases (828)
Real estate (5954)
Recruiting (70)
Regulatory (24460)
Reports (52)
Research institute (2386)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (76)
Schizophrenia (146)
Series A (238)
Series B (190)
Service/supplier (11)
Sickle cell disease (95)
Special edition (21)
Spinal muscular atrophy (157)
Sponsored (41)
Startups (3614)
State (2)
Stomach cancer (17)
Supply chain (104)
Tariffs (84)
The Weekly (55)
Vaccines (996)
Venture capital (87)
Weight loss (379)
Women's health (89)
Worklife (18)
Date
Today (126)
Last 7 days (577)
Last 30 days (2058)
Last 365 days (29883)
2026 (3233)
2025 (30173)
2024 (35216)
2023 (40076)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (308)
Arkansas (13)
Asia (39207)
Australia (6407)
California (11241)
Canada (3269)
China (1094)
Colorado (476)
Connecticut (472)
Delaware (335)
Europe (84485)
Florida (1676)
Georgia (354)
Hawaii (3)
Idaho (61)
Illinois (854)
India (64)
Indiana (518)
Iowa (22)
Japan (424)
Kansas (126)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1375)
Massachusetts (8056)
Michigan (323)
Minnesota (624)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (121)
New Hampshire (78)
New Jersey (2989)
New Mexico (28)
New York (2963)
North Carolina (1447)
North Dakota (8)
Northern California (5488)
Ohio (331)
Oklahoma (21)
Oregon (41)
Pennsylvania (2269)
Puerto Rico (24)
Rhode Island (47)
South America (1108)
South Carolina (65)
South Dakota (1)
Southern California (4374)
Tennessee (174)
Texas (1735)
United States (39839)
Utah (334)
Vermont (1)
Virginia (259)
Washington D.C. (81)
Washington State (917)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
721,506 Results for "arcellx inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arcellx Announces Late-Breaking Presentation at TANDEM Demonstrating Unique, High Target-Specificity of anito-cel’s D-Domain Binder
February 5, 2026
·
8 min read
Press Releases
Arcellx to Advance the Conversation on Its Platform and the Importance of Early CAR T Access for Patients with Multiple Myeloma During the 2026 Tandem Meetings
January 22, 2026
·
6 min read
Press Releases
Arcellx Provides Third Quarter 2025 Financial Results
November 5, 2025
·
4 min read
Press Releases
Arcellx to Host Investor Relations Event During the 67th ASH Annual Meeting and Exposition
November 19, 2025
·
2 min read
Press Releases
Arcellx to Participate at the 2025 Morgan Stanley Global Healthcare Conference
September 4, 2025
·
2 min read
Press Releases
Arcellx to Present New Data for Its iMMagine-1 Study and Continues Scientific Momentum with Multiple Presentations at the 67th ASH Annual Meeting and Exposition
November 3, 2025
·
6 min read
Press Releases
Arcellx Provides Second Quarter 2025 Financial Results and Business Highlights
August 8, 2025
·
8 min read
Biotech Bay
Arcellx to Participate in Two Upcoming May 2024 Investor Conferences
Arcellx, Inc. announced that management will participate in two upcoming investor conferences.
May 7, 2024
·
2 min read
Press Releases
Arcellx Provides First Quarter 2025 Financial Results and Business Highlights
May 8, 2025
·
8 min read
Business
Arcellx Provides First Quarter 2024 Financial Results
Arcellx, Inc., a biotechnology company reimagining cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases, reported business highlights and financial results for the first quarter ended March 31, 2024.
May 9, 2024
·
5 min read
1 of 72,151
Next
